xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

418

KUANetal.

1093. Dooley L, Shah J. Management of the neck in maxil lary sinus carcinomas. Curr Opin Otolaryngol Head Neck Surg . 2015;23(2):107-114. https://doi.org/10.1097/MOO. 0000000000000138 1094. Ahn PH, Mitra N, Alonso-Basanta M, et al. Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta Oncol . 2016;55(9-10):1107-1114. https://doi.org/10.1080/0284186x.2016.1216656 1095. Galloni C, Locatello LG, Bruno C, Cannavicci A, Maggiore G, Gallo O. The role of elective neck treatment in the man agement of sinonasal carcinomas: a systematic review of the literature and a meta-analysis. Cancers . 2021;13(8):1842. https://doi.org/10.3390/cancers13081842 1096. Sangal NR, Lee Y, Brady JS, et al. The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma. Laryngoscope . 2017;128(8):1835-1841. https://doi. org/10.1002/lary.27009 1097. Abu-Ghanem S, Horowitz G, Abergel A, et al. Elective neck irradiation versus observation in squamous cell carcinoma of the maxillary sinus with N0 neck: a meta-analysis and review of the literature. HeadNeck . 2014;37(12):1823-1828. https://doi. org/10.1002/hed.23791 1098. Le QT, Fu KK, Kaplan MJ, Terris DJ, Fee WE, Goffinet DR. Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys . 2000;46(3):541-549. https://doi.org/10. 1016/s0360-3016(99)00453-8 1099. Cantù G, Bimbi G, Miceli R, et al. Lymph node metastases in malignant tumors of the paranasal sinuses. Arch Otolaryngol Head Neck Surg . 2008;134(2):170-177. https://doi.org/10.1001/ archoto.2007.30 1100. Crawford KL, Jafari A, Qualliotine JR, et al. Elective neck dissection for T3 /T4 cN0 sinonasal squamous cell carci noma. Head Neck . 2020;42(12):3655-3662. https://doi.org/10. 1002/hed.26418 1101. Berger MH, Tajudeen BA, St John MA, Tjoa T, Kuan EC. Should an elective neck dissection be performed for maxillary sinus squamous cell carcinoma? Laryngoscope . 2019;129(11):2445-2446. https://doi.org/10.1002/lary.28242 1102. Homma A, Hayashi R, Matsuura K, et al. Lymph node metastasis in T4 maxillary sinus squamous cell carci noma: incidence and treatment outcome. Ann Surg Oncol . 2014;21(5):1706-1710. https://doi.org/10.1245/s10434-014-3544 6 1103. Riobello C, Vivanco B, Reda S, et al. Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer. Head Neck . 2018;40(4):818-827. https://doi.org/10. 1002/hed.25067 1104. García-Marín R, Reda S, Riobello C, et al. Prognostic and therapeutic implications of immune classification by CD8( + ) tumor-infiltrating lymphocytes and PD-L1 expres sion in sinonasal squamous cell carcinoma. Int J Mol Sci . 2021;22(13):6926. https://doi.org/10.3390/ijms22136926 1105. Kim JH, Lee YS, Chung YS, et al. Treatment out comes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: a single institution study. Acta Otolaryngol . 2015;135(11):1189-1195. https://doi.org/10.3109/00016489.2015.1061697

1080. Teitelbaum JI, Issa K, Barak IR, et al. Sinonasal squamous cell carcinoma outcomes: does treatment at a high-volume center confer survival benefit? Otolaryngol Head Neck Surg . 2020;163(5):986-991. https://doi.org/10.1177/0194599820935395 1081. Inuyama Y, Fujii M, Tanaka J, et al. Neoadjuvant chemother apy in maxillary sinus carcinoma with cisplatinum and peplomycin intraarterial infusion. Auris Nasus Lar ynx . 1985;12:S249-S254. https://doi.org/10.1016/s0385 8146(85)80068-7 1082. Nakatani H, Hirose K, Matsumoto N, et al. A totally implanted intra-arterial chemotherapy system for advanced maxillary sinus carcinoma. ORL J Otorhinolaryngol Relat Spec . 2009;71(Suppl. 1):116-122. https://doi.org/10.1159/000265123 1083. Shiga K, Yokoyama J, Hashimoto S, et al. Combined ther apy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg . 2007;136(6):1003-1009. https://doi.org/10.1016/j.otohns. 2006.12.018 1084. Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY. Endoscopic resection of sinonasal cancers. Curr Oncol Rep . 2014;16(2):369. https://doi.org/10.1007/s11912-013 0369-6 1085. Rawal RB, Farzal Z, Federspiel JJ, Sreenath SB, Thorp BD, Zanation AM. Endoscopic resection of sinonasal malig nancy: a systematic review and meta-analysis. Otolaryngol Head Neck Surg . 2016;155(3):376-386. https://doi.org/10.1177/ 0194599816646968 1086. Luong A, Citardi MJ, Batra PS. Management of sinonasal malignant neoplasms: defining the role of endoscopy. Am J Rhinol Allergy . 2010;24(2):150-155. https://doi.org/10.2500/ ajra.2010.24.3451 1087. Xiao R, Joshi RR, Husain Q, et al. Timing of surgery and adju vant radiation therapy for sinonasal malignancies: effect of surgical approach. HeadNeck . 2019;41(10):3551-3563. https:// doi.org/10.1002/hed.25873 1088. Cooper JS, Pajak TF, Forastiere AA, et al. Postopera tive concurrent radiotherapy and chemotherapy for high risk squamous-cell carcinoma of the head and neck. N Engl J Med . 2004;350(19):1937-1944. https://doi.org/10.1056/ nejmoa032646 1089. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med . 2004;350(19):1945-1952. https://doi.org/10.1056/nejmoa032641 1090. Homma A, Onimaru R, Matsuura K, et al. Dose-finding and efficacy confirmation trial of the superselective intra arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clini cal Oncology Group 1212): dose-finding phase. Head Neck . 2017;40(3):475-484. https://doi.org/10.1002/hed.25001 1091. Qiu X, Yang J. Clinical study of cetuximab combined with radical radiotherapy in the treatment of locally advanced sinonasal squamous cell carcinoma. J BUON . 2018;23(4):1111 1117. 1092. Mimica X, Yu Y, McGill M, et al. Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: rhinectomy-free survival in those refusing surgery. Head Neck . 2019;41(8):2741-2747. https://doi.org/10. 1002/hed.25751